The prognostic role of neutrophil/lymphocyte ratio and monocyte/lymphocyte ratio in advanced stage gastric cancer patients receiving chemotherapy: a single center experience
Open Access
- 31 August 2023
- journal article
- research article
- Published by Hatay Mustafa Kemal University Faculty of Medicine in Interdisciplinary Medical Journal
- Vol. 14 (49) , 100-104
Abstract
Objective: Several studies revealed that peripheral blood Neutrophil/Lymphocyte ratio (NLR) and Monocyte/Lymphocyte Ratio (MLR) were prognostic in various cancer types. However, there are no excessive information about the prognostic significance of NLR and MLR in patients with advanced gastric cancer. As a result, we examined whether NLR and/or MLR could be used as a prognostic marker to predict survival outcomes in patients with advanced gastric cancer receiving palliative chemotherapy. Method: We retrospectively analyzed 119 patients with gastric cancer receiving chemotherapy. We evaluated the relationship between potential prognostic factors and overall survival (OS) times using the Kaplan-Meier method and Cox regression survival modelling. Results: The median overall survival of the patients was 6.9 (2.1-41.6) months. In univariate analysis, NLR (p< 0.001), ECOG performance status (p< 0.001), presence of liver metastases (p< 0.001) and presence of peritoneal metastases (p< 0.001) were found to be associated with survival. The multivariate survival model showed the high NLR (HR=1.59, 95% CI 1.6-2.40, p= 0.026), the patients with ECOG performance score 2-3 (HR=2.91, 95% CI 1.60-5.27, p<0.001), the presence of liver metastasis (HR=2.10, 95% CI 1.35-3.21, p=0.001) and the presence of peritoneal metastases (HR=2.68, 95% CI 1.72-4.17, p<0.001) as independent predictors of survival. Conclusion: Pretreatment high NLR, ECOG performance status, and presence of liver or peritoneal metastases are powerful prognostic factors in advanced gastric cancer patients. These prognostic factors, which are easily accessible in clinical practice, can be used as helpful tools for clinicians in the management of the disease.Keywords
This publication has 24 references indexed in Scilit:
- Lymphocyte-to-monocyte ratios predict gastric cancer surgical outcomesJournal of Surgical Research, 2016
- Pre-treatment neutrophil to lymphocyte ratio as a prognostic marker to predict chemotherapeutic response and survival outcomes in metastatic advanced gastric cancerGastric Cancer, 2014
- Elevated preoperative neutrophil to lymphocyte ratio predicts poor survival following resection in late stage gastric cancerJournal of Surgical Oncology, 2011
- Evaluations of interferon‐γ/interleukin‐4 ratio and neutrophil/lymphocyte ratio as prognostic indicators in gastric cancer patientsJournal of Surgical Oncology, 2010
- High preoperative neutrophil-lymphocyte ratio predicts poor survival in patients with gastric cancerGastric Cancer, 2010
- Prognostic Significance of Serum Vascular Endothelial Growth Factor Per Platelet Count in Unresectable Advanced Gastric Cancer PatientsJapanese Journal of Clinical Oncology, 2010
- Age-Specific Trends in Incidence of Noncardia Gastric Cancer in US AdultsJAMA, 2010
- Prognostic model to predict survival following first-line chemotherapy in patients with metastatic gastric adenocarcinomaAnnals of Oncology, 2007
- Multivariate Prognostic Factor Analysis in Locally Advanced and Metastatic Esophago-Gastric Cancer—Pooled Analysis From Three Multicenter, Randomized, Controlled Trials Using Individual Patient DataJournal of Clinical Oncology, 2004
- Stomach Cancer and Food StorageJNCI: Journal of the National Cancer Institute, 1989